This study is looking at how well a treatment called bilateral middle meningeal artery lidocaine infusion works for people with chronic, very severe migraines. This treatment involves carefully putting lidocaine, a common numbing medicine, into specific blood vessels in your head. The goal is to numb pain receptors that cause chronic headaches, which might reduce how often, how long, and how bad your migraines are. To join, you must be between 18 and 75 years old and have chronic daily headaches (more than 15 headache days a month for at least 3 months) that haven't improved with at least three other preventive treatments. The study aims to see if this treatment reduces your monthly migraine headache days over three months after the procedure. The current status of this study is unclear, and it plans to enroll 40 participants.

Study design

This is an interventional study that plans to enroll 40 participants. It is an observational study designed to gather data before and after the lidocaine procedure.

What's involved

If you meet the eligibility criteria at your first visit, you will be scheduled for the lidocaine procedure. The study will then track your migraine headache days from enrollment up to three months after the treatment.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for three months after the treatment to measure the reduction in monthly migraine headache days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.